CERo Therapeutics Holdings, Inc.
Why Robinhood?
You can watch CERO and buy or sell other stocks, ETFs, and their options commission-free!About CERO
CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors.
CERO Key Statistics
Stock Snapshot
As of today, CERo Therapeutics Holdings, Inc.(CERO) shares are valued at $0.10. The company's market cap stands at 19.3M, with a P/E ratio of -11.94.
During the trading day, CERo Therapeutics Holdings, Inc.(CERO) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 136.31M.
The stock's 52-week range extends from a low of $3.99 to a high of $1,280.00.
The stock's 52-week range extends from a low of $3.99 to a high of $1,280.00.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.